Logotype for Novonix Limited

Novonix (NVX) H1 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Novonix Limited

H1 2026 earnings summary

31 Aug, 2026

Executive summary

  • Delivered a C-sample of synthetic graphite anode material to Panasonic, meeting internal specs and advancing qualification for mass production targeted for H2 2027, subject to Panasonic validation.

  • Completed divestiture of Battery Technology Solutions (BTS), focusing on core synthetic graphite business and retaining a 15% equity stake in Dryve's cathode business.

  • Raised A$20.7 million via institutional placement and A$0.96 million through a share purchase plan to support operations and expansion.

  • U.S. government support includes a $100 million DOE grant, $103 million in Section 48C tax credits, and a conditional $754.8 million DOE loan commitment for facility expansion.

Financial highlights

  • Net loss from continuing operations was $23.6 million for H1 2026, compared to $17.5 million in H1 2025; total net loss including discontinued operations was $24.6 million (vs. $20.1 million prior year).

  • Revenue from continuing operations was $1.1 million, down from $2.8 million year-over-year.

  • Cash and cash equivalents at June 30, 2026, were $59.5 million, down from $79.9 million at December 31, 2025.

  • Net assets decreased by $4.3 million to $157.3 million over the six-month period.

  • Net tangible asset backing per share was $0.15, down from $0.21 year-over-year.

Outlook and guidance

  • Mass production for Panasonic expected to commence in H2 2027, contingent on successful qualification.

  • North American synthetic graphite demand projected to grow 46% YoY by end of 2026, with regional share of global anode capacity forecast to rise to 4% by 2035.

  • Ongoing engagement with U.S. government and industry stakeholders to secure additional funding and policy support.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more